Rubicon Genomics

company

About

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$3.50M
Industries
Biotechnology,Genetics
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medicine applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy.

Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan and employs 20 administrative and technical staff. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies that "break the sample barriers" for our customers. Rubicon sells its products into the research and commercial markets directly and through distributors

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.50M
Rubicon Genomics has raised a total of $3.50M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2002 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2002 Series B $3.50M 1 Arch Development Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Rubicon Genomics is funded by 1 investors. Arch Development Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Arch Development Partners Yes Series B